Skip to main navigation Skip to search Skip to main content

Prevention and treatment of cryptosporidiosis in immunocompromised patients: A Cochrane review

  • Ibrahim I. Abubakar
  • , Sani H. Aliyu
  • , Chitra Arumugam
  • , Paul R. Hunter
  • , Nuhu Usman

Research output: Contribution to journal › Article

181 Citations (Scopus)

Abstract

Cryptosporidiosis is a disease that causes diarrhoea, and can be life‐threatening in individuals whose bodies are not able to resist infections. It causes disease in the both the developed and the developing world. This review of trials found insufficient evidence to say whether any drug is able to reduce or cure the symptoms of Cryptosporidium infection or to effectively kill the organism among individuals who cannot resist infections. A limited amount of evidence was found indicating that the drug nitaxozanide can kill the organism in individuals with a normal immunity.
Original languageEnglish
Article numberCD004932
JournalCochrane Database of Systematic Reviews
Volume1
DOIs
Publication statusPublished - 2007

Cite this